PlexusDx providers work with you to assess whether ongoing therapy aligns with your goals or if a maintenance phase makes sense for your specific situation
The incidence rate of NAION was 14.5 per 100,000 person-years among semaglutide users
Participants were randomized to receive tirzepatide at doses of 5 mg, 10 mg, or 15 mg weekly, or placebo, for 176 weeks (over three years), followed by a 17-week off-treatment period
Ideal for those interested in skin health, wound healing, and neurological protection
At Aguaviva, were committed to helping you make informed decisions about your weight loss journey
"The unregulated 'grey market' also creates a dangerous transparency gap